These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 11220665)

  • 1. Lung cancer: chemoprevention and intermediate effect markers.
    Tockman MS
    IARC Sci Publ; 2001; 154():257-70. PubMed ID: 11220665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surrogate end-point biomarker analysis in a retinol chemoprevention trial in current and former smokers with bronchial dysplasia.
    Lam S; Xu X; Parker-Klein H; Le Riche JC; Macaulay C; Guillaud M; Coldman A; Gazdar A; Lotan R
    Int J Oncol; 2003 Dec; 23(6):1607-13. PubMed ID: 14612933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical detection of lung cancer progression markers.
    Tockman MS
    J Cell Biochem Suppl; 1996; 25():177-84. PubMed ID: 9027616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surrogate end-point biomarkers in chemopreventive drug development.
    Kelloff GJ; Sigman CC; Hawk ET; Johnson KM; Crowell JA; Guyton KZ
    IARC Sci Publ; 2001; 154():13-26. PubMed ID: 11220652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-(4-hydroxyphenyl)retinamide in the chemoprevention of squamous metaplasia and dysplasia of the bronchial epithelium.
    Kurie JM; Lee JS; Khuri FR; Mao L; Morice RC; Lee JJ; Walsh GL; Broxson A; Lippman SM; Ro JY; Kemp BL; Liu D; Fritsche HA; Xu X; Lotan R; Hong WK
    Clin Cancer Res; 2000 Aug; 6(8):2973-9. PubMed ID: 10955773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoprevention of lung cancer.
    Hong WK
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):135-41. PubMed ID: 10550838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetics of small cell lung carcinoma.
    Wistuba II; Gazdar AF; Minna JD
    Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecularly targeted approaches to the chemoprevention of lung cancer.
    Khuri FR; Cohen V
    Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4249s-4253s. PubMed ID: 15217968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of proliferating cell nuclear antigen in the bronchial epithelium of smokers.
    Khuri FR; Lee JS; Lippman SM; Lee JJ; Kalapurakal S; Yu R; Ro JY; Morice RC; Hong WK; Hittelman WN
    Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):311-8. PubMed ID: 11319170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoids: application in premalignant lesions and oral cancer.
    Contreras Vidaurre EG; Bagán Sebastián JV; Gavalda C; Torres Cifuentes EF
    Med Oral; 2001; 6(2):114-23. PubMed ID: 11500628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoid chemoprevention studies in upper aerodigestive tract and lung carcinogenesis.
    Lippman SM; Benner SE; Hong WK
    Cancer Res; 1994 Apr; 54(7 Suppl):2025s-2028s. PubMed ID: 8137332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarker and animal models for assessment of retinoid efficacy in cancer chemoprevention.
    Niles RM
    Acta Pharmacol Sin; 2007 Sep; 28(9):1383-91. PubMed ID: 17723172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemoprevention of lung cancer. A review about previous studies, results and future developments].
    Heckmayr M
    Pneumologie; 2004 Jun; 58(6):408-15. PubMed ID: 15216434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoids as cancer-preventive agents.
    Sankaranarayanan R; Mathew B
    IARC Sci Publ; 1996; (139):47-59. PubMed ID: 8923019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoprevention of lung cancer: from concept to reality.
    van Zandwijk N
    Rocz Akad Med Bialymst; 2003; 48():5-10. PubMed ID: 14737934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of c-ErbB1/epidermal growth factor receptor and c-ErbB2/HER-2 expression in bronchial dysplasia: evaluation of potential targets for chemoprevention of lung cancer.
    Merrick DT; Kittelson J; Winterhalder R; Kotantoulas G; Ingeberg S; Keith RL; Kennedy TC; Miller YE; Franklin WA; Hirsch FR
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2281-8. PubMed ID: 16609045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinogen biomarkers for lung or oral cancer chemoprevention trials.
    Hecht SS
    IARC Sci Publ; 2001; 154():245-55. PubMed ID: 11220664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers.
    Belinsky SA; Palmisano WA; Gilliland FD; Crooks LA; Divine KK; Winters SA; Grimes MJ; Harms HJ; Tellez CS; Smith TM; Moots PP; Lechner JF; Stidley CA; Crowell RE
    Cancer Res; 2002 Apr; 62(8):2370-7. PubMed ID: 11956099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The early detection of occult lung cancer.
    Tockman MS; Mulshine JL
    Chest Surg Clin N Am; 2000 Nov; 10(4):737-49. PubMed ID: 11091923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung cancer chemoprevention: an integrated approach.
    Lippman SM; Spitz MR
    J Clin Oncol; 2001 Sep; 19(18 Suppl):74S-82S. PubMed ID: 11560978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.